GW&K Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.9M | Sell |
1,264,806
-117,635
| -9% | -$3.71M | 0.36% | 106 |
|
|
2025
Q1 | $45.3M | Buy |
1,382,441
+176,091
| +15% | +$5.77M | 0.42% | 85 |
|
|
2024
Q4 | $43.6M | Sell |
1,206,350
-31,665
| -3% | -$1.14M | 0.37% | 106 |
|
|
2024
Q3 | $38.6M | Sell |
1,238,015
-55,300
| -4% | -$1.72M | 0.33% | 124 |
|
|
2024
Q2 | $34.6M | Sell |
1,293,315
-46,127
| -3% | -$1.23M | 0.32% | 130 |
|
|
2024
Q1 | $45.7M | Buy |
1,339,442
+21,916
| +2% | +$748K | 0.4% | 99 |
|
|
2023
Q4 | $38.1M | Sell |
1,317,526
-88,632
| -6% | -$2.56M | 0.36% | 118 |
|
|
2023
Q3 | $38.8M | Buy |
1,406,158
+6,903
| +0.5% | +$190K | 0.39% | 103 |
|
|
2023
Q2 | $42.1M | Sell |
1,399,255
-16,849
| -1% | -$506K | 0.4% | 100 |
|
|
2023
Q1 | $51.3M | Buy |
1,416,104
+9,576
| +0.7% | +$347K | 0.5% | 83 |
|
|
2022
Q4 | $50.2M | Sell |
1,406,528
-360,961
| -20% | -$12.9M | 0.51% | 74 |
|
|
2022
Q3 | $59.8M | Sell |
1,767,489
-142,360
| -7% | -$4.82M | 0.66% | 36 |
|
|
2022
Q2 | $55.2M | Buy |
1,909,849
+82,758
| +5% | +$2.39M | 0.6% | 51 |
|
|
2022
Q1 | $59.1M | Sell |
1,827,091
-9,375
| -0.5% | -$303K | 0.53% | 62 |
|
|
2021
Q4 | $53.6M | Buy |
1,836,466
+210,976
| +13% | +$6.15M | 0.45% | 88 |
|
|
2021
Q3 | $43.4M | Buy |
1,625,490
+9,390
| +0.6% | +$250K | 0.39% | 107 |
|
|
2021
Q2 | $49.8M | Buy |
1,616,100
+42,689
| +3% | +$1.31M | 0.43% | 83 |
|
|
2021
Q1 | $41.2M | Buy |
1,573,411
+256,071
| +19% | +$6.7M | 0.38% | 115 |
|
|
2020
Q4 | $33.1M | Buy |
1,317,340
+267,452
| +25% | +$6.73M | 0.35% | 133 |
|
|
2020
Q3 | $21.9M | Buy |
1,049,888
+259,087
| +33% | +$5.4M | 0.29% | 149 |
|
|
2020
Q2 | $18.8M | Buy |
+790,801
| New | +$18.8M | 0.26% | 166 |
|